{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T21:52:58Z","timestamp":1720734778779},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T00:00:00Z","timestamp":1280188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s11899-010-0059-5","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T04:01:14Z","timestamp":1280116874000},"page":"192-199","source":"Crossref","is-referenced-by-count":5,"title":["Stem Cell Transplantation in Childhood Non-Hodgkin\u2019s Lymphomas"],"prefix":"10.1007","volume":"5","author":[{"given":"Fatma V.","family":"Okur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Krance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,27]]},"reference":[{"key":"59_CR1","unstructured":"National Cancer Institute: Surveillance, Epidemiology and End Results (SEER) Program. Available at http:\/\/seer.cancer.gov\/statistics\/ . Accessed June 30, 2010."},{"key":"59_CR2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.seminoncol.2009.07.009","volume":"36","author":"SM Jaglowski","year":"2009","unstructured":"Jaglowski SM, Linden E, Termuhlen AM, Flynn JM: Lymphoma in adolescents and young adults. Semin Oncol 2009, 36:381\u2013418.","journal-title":"Semin Oncol"},{"key":"59_CR3","first-page":"1665","volume":"43","author":"C Patte","year":"1993","unstructured":"Patte C: Non-Hodgkin\u2019s lymphomas in children [in French]. Rev Prat 1993, 43:1665\u20131668.","journal-title":"Rev Prat"},{"key":"59_CR4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.1995.13.2.359","volume":"13","author":"A Reiter","year":"1995","unstructured":"Reiter A, Schrappe M, Parwaresch R, et al.: Non-Hodgkin\u2019s lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage\u2014a report of the Berlin-Frankfurt-M\u00fcnster group. J Clin Oncol 1995, 13:359\u2013372.","journal-title":"J Clin Oncol"},{"key":"59_CR5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1997.15.2.509","volume":"15","author":"I Majolino","year":"1997","unstructured":"Majolino I, Pearce R, Taghipour G, Goldstone AH: Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry data. J Clin Oncol 1997, 15:509\u2013517.","journal-title":"J Clin Oncol"},{"key":"59_CR6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1703515","volume":"29","author":"T Flohr","year":"2002","unstructured":"Flohr T, Hess G, Kolbe K, et al.: Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL. Bone Marrow Transplant 2002, 29:769\u2013775.","journal-title":"Bone Marrow Transplant"},{"key":"59_CR7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1182\/blood-2003-04-1257","volume":"103","author":"SM Horwitz","year":"2004","unstructured":"Horwitz SM, Negrin RS, Blume KG, et al.: Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood 2004, 103:777\u2013783.","journal-title":"Blood"},{"key":"59_CR8","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2005.08.012","volume":"23","author":"IF Khouri","year":"2005","unstructured":"Khouri IF, Saliba RM, Hosing C, et al.: Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin\u2019s lymphomas. J Clin Oncol 2005, 23:2240\u20132247.","journal-title":"J Clin Oncol"},{"key":"59_CR9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1200\/JCO.2003.07.113","volume":"21","author":"JO Armitage","year":"2003","unstructured":"Armitage JO, Carbone PP, Connors JM, et al.: Treatment-related myelodysplasia and acute leukemia in non-Hodgkin\u2019s lymphoma patients. J Clin Oncol 2003, 21:897\u2013906.","journal-title":"J Clin Oncol"},{"key":"59_CR10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bmt.1704124","volume":"32","author":"R Howe","year":"2003","unstructured":"Howe R, Micallef IN, Inwards DJ, et al.: Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma. Bone Marrow Transplant 2003, 32:317\u2013324.","journal-title":"Bone Marrow Transplant"},{"key":"59_CR11","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3324\/haematol.11185","volume":"92","author":"N Schmitz","year":"2007","unstructured":"\u2022 Schmitz N, Dreger P, Glass B, Sureda A: Allogeneic transplantation in lymphoma: current status. Haematologica 2007, 92:1533\u20131548. This review summarizes the results of allo-HSCT after both myeloablative conditioning and reduced-intensity conditioning and discusses the evidence to support the existence of GvL effect.","journal-title":"Haematologica"},{"key":"59_CR12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bmt.1703891","volume":"31","author":"AJ Peniket","year":"2003","unstructured":"Peniket AJ, Ruiz de Elvira MC, Taghipour G, et al.: An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: Allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplant 2003, 31:667\u2013678.","journal-title":"Bone Marrow Transplant"},{"key":"59_CR13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1705074","volume":"36","author":"NH Russell","year":"2005","unstructured":"Russell NH, Byrne JL, Faulkner RD, et al.: Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant 2005, 36:437\u2013441.","journal-title":"Bone Marrow Transplant"},{"key":"59_CR14","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","volume":"22","author":"P Corradini","year":"2004","unstructured":"Corradini P, Dodero A, Zallio F, et al.: Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin\u2019s lymphoma after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 2004, 22:2172\u20132176.","journal-title":"J Clin Oncol"},{"key":"59_CR15","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood-2007-05-091280","volume":"110","author":"CM Bollard","year":"2007","unstructured":"Bollard CM, Gottschalk S, Leen AM, et al.: Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood 2007, 110:2838\u20132845.","journal-title":"Blood"},{"key":"59_CR16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1532\/IJH97.A30505","volume":"83","author":"HI Cho","year":"2006","unstructured":"Cho HI, Hong YS, Lee MA, et al.: Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomas. Int J Hematol 2006, 83:66\u201373.","journal-title":"Int J Hematol"},{"key":"59_CR17","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1182\/blood-2004-03-1208","volume":"105","author":"LJ Cooper","year":"2005","unstructured":"Cooper LJ, Al-Kadhimi Z, Serrano LM, et al.: Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1. Blood 2005, 105:1622\u20131631.","journal-title":"Blood"},{"key":"59_CR18","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1200\/JCO.1993.11.6.1024","volume":"11","author":"JR Anderson","year":"1993","unstructured":"Anderson JR, Jenkin RD, Wilson JF, et al.: Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood Non-Hodgkin\u2019s lymphoma: a report of CCG-551 from the Childrens Cancer Group. J Clin Oncol 1993, 11:1024\u20131032.","journal-title":"J Clin Oncol"},{"key":"59_CR19","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","volume":"97","author":"C Patte","year":"2001","unstructured":"Patte C, Auperin A, Michon J, et al.: The Societe Francaise d\u2019Oncologie Pediatrique LMB89 protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001, 97:3370\u20133379.","journal-title":"Blood"},{"key":"59_CR20","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","volume":"109","author":"C Patte","year":"2007","unstructured":"Patte C, Auperin A, Gerrard M, et al.: Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: It is possible to reduce treatment for the early responding patients. Blood 2007, 109:2773\u20132780.","journal-title":"Blood"},{"key":"59_CR21","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.1996.14.4.1252","volume":"14","author":"WP Bowman","year":"1996","unstructured":"Bowman WP, Shuster JJ, Cook B, et al.: Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a Pediatric Oncology Group study. J Clin Oncol 1996, 14:1252\u20131261.","journal-title":"J Clin Oncol"},{"key":"59_CR22","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","volume":"105","author":"W Woessmann","year":"2005","unstructured":"Woessmann W, Seidemann K, Mann G, et al.: The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: A report of the BFM Group study NHL-BFM95. Blood 2005, 105:948\u2013958.","journal-title":"Blood"},{"key":"59_CR23","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","volume":"109","author":"MS Cairo","year":"2007","unstructured":"Cairo MS, Gerrard M, Sposto R, et al.: Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood 2007, 109:2736\u20132743.","journal-title":"Blood"},{"key":"59_CR24","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/cncr.11615","volume":"98","author":"J Mora","year":"2003","unstructured":"Mora J, Filippa DA, Qin J, Wollner N: Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial Sloan-Kettering Cancer Center. Cancer 2003, 98:1283\u20131291.","journal-title":"Cancer"},{"key":"59_CR25","first-page":"416","volume":"95","author":"A Reiter","year":"2000","unstructured":"Reiter A, Schrappe M, Ludwig WD, et al.: Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: A BFM Group report. Blood 2000, 95:416\u2013421.","journal-title":"Blood"},{"key":"59_CR26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.2005.02.2707","volume":"24","author":"B Burkhardt","year":"2006","unstructured":"Burkhardt B, Woessmann W, Zimmermann M, et al.: Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J Clin Oncol 2006, 24:491\u2013499.","journal-title":"J Clin Oncol"},{"issue":"7","key":"59_CR27","first-page":"867","volume":"46","author":"C Bergeron","year":"2006","unstructured":"Bergeron C, Celine S, Pacquement H, et al.: Childhood T cell lymphoblastic lymphoma (TLL) results of the SFOP LMT96 strategy [abstract 101]. Pediatr Blood Cancer 2006, 46(7):867.","journal-title":"Pediatr Blood Cancer"},{"key":"59_CR28","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood.V97.12.3699","volume":"97","author":"K Seidemann","year":"2001","unstructured":"Seidemann K, Tiemann M, Schrappe M, et al.: Short-pulse B-non-Hodgkin lymphoma\u2013type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-M\u00fcnster Group trial NHL-BFM 90. Blood 2001, 97:3699\u20133706.","journal-title":"Blood"},{"key":"59_CR29","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/cncr.21438","volume":"104","author":"A Rosolen","year":"2005","unstructured":"Rosolen A, Pillon M, Garaventa A, et al.: Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 Protocol. Cancer 2005, 104:2133\u20132140.","journal-title":"Cancer"},{"issue":"7","key":"59_CR30","first-page":"842","volume":"46","author":"B Burkhardt","year":"2006","unstructured":"Burkhardt B, Reiter A, Lang P, et al.: Relapse in pediatric pts with T-cell lymphoblastic lymphoma: clinical characteristics and outcome in the BFM Group [abstract 25]. Pediatr Blood Cancer 2006, 46(7):842.","journal-title":"Pediatr Blood Cancer"},{"key":"59_CR31","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood.V90.8.2921","volume":"90","author":"R Ladenstein","year":"1997","unstructured":"Ladenstein R, Pearce R, Hartmann O, et al.: High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt\u2019s lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry. Blood 1997, 90:2921\u20132930.","journal-title":"Blood"},{"key":"59_CR32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1200\/JCO.1999.17.3.825","volume":"17","author":"KS Baker","year":"1999","unstructured":"Baker KS, Gordon BG, Gross TG, et al.: Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin\u2019s disease in children and adolescents. J Clin Oncol 1999, 17:825\u2013831.","journal-title":"J Clin Oncol"},{"key":"59_CR33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbmt.2009.09.021","volume":"16","author":"TG Gross","year":"2010","unstructured":"\u2022 Gross TG, Hale GA, He W, et al.: Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. Biol Blood Marrow Transplant 2010, 16:223\u2013230. These registry data provide the largest experience for both auto-SCT and allo-SCT across the spectrum of pediatric non-Hodgkin\u2019s lymphoma.","journal-title":"Biol Blood Marrow Transplant"},{"key":"59_CR34","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","volume":"10","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, et al.: The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999, 10:1419\u20131432.","journal-title":"Ann Oncol"},{"key":"59_CR35","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","volume":"102","author":"KJ Savage","year":"2003","unstructured":"Savage KJ, Monti S, Kutok JL, et al.: The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003, 102:3871\u20133879.","journal-title":"Blood"},{"key":"59_CR36","first-page":"353","volume":"15","author":"E Bureo","year":"1995","unstructured":"Bureo E, Ortega JJ, Munoz A, et al.: Bone marrow transplantation in 46 pediatric patients with non-Hodgkin\u2019s lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children. Bone Marrow Transplant 1995, 15:353\u2013359.","journal-title":"Bone Marrow Transplant"},{"key":"59_CR37","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.leu.2403733","volume":"19","author":"GW Imhoff van","year":"2005","unstructured":"van Imhoff GW, van der Holt B, MacKenzie MA, et al.: Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia 2005, 19:945\u2013952.","journal-title":"Leukemia"},{"key":"59_CR38","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2141.2006.06080.x","volume":"133","author":"KW Song","year":"2006","unstructured":"Song KW, Barnett MJ, Gascoyne RD, et al.: Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma. Br J Haematol 2006, 133:634\u2013637.","journal-title":"Br J Haematol"},{"key":"59_CR39","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00277-006-0169-2","volume":"85","author":"SC Won","year":"2006","unstructured":"Won SC, Han JW, Kwon SY, et al.: Autologous peripheral blood stem cell transplantation in children with non-Hodgkin\u2019s lymphoma: a report from the Korean Society Of Pediatric Hematology-Oncology. Ann Hematol 2006, 85:787\u2013794.","journal-title":"Ann Hematol"},{"key":"59_CR40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","volume":"131","author":"B Burkhardt","year":"2005","unstructured":"Burkhardt B, Zimmermann M, Oschlies I, et al.: The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol 2005, 131:39\u201349.","journal-title":"Br J Haematol"},{"key":"59_CR41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, et al.: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002, 346:235\u2013242.","journal-title":"N Engl J Med"},{"key":"59_CR42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503\u2013511.","journal-title":"Nature"},{"key":"59_CR43","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2005-10-4213","volume":"107","author":"I Oschlies","year":"2006","unstructured":"Oschlies I, Klapper W, Zimmermann M, et al.: Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-M\u00fcnster) multicenter trial. Blood 2006, 107:4047\u20134052.","journal-title":"Blood"},{"key":"59_CR44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pbc.21619","volume":"51","author":"RR Miles","year":"2008","unstructured":"Miles RR, Raphael M, McCarthy K, et al.: Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) International Study Group. Pediatr Blood Cancer 2008, 51:369\u2013374.","journal-title":"Pediatr Blood Cancer"},{"key":"59_CR45","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","volume":"7","author":"M Pfreundschuh","year":"2006","unstructured":"Pfreundschuh M, Trumper L, Osterborg A, et al.: CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MINT) group. Lancet Oncol 2006, 7:379\u2013391.","journal-title":"Lancet Oncol"},{"key":"59_CR46","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","volume":"24","author":"TM Habermann","year":"2006","unstructured":"Habermann TM, Weller EA, Morrison VA, et al.: Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 2006, 24:3121\u20133127.","journal-title":"J Clin Oncol"},{"key":"59_CR47","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/sj.leu.2404844","volume":"21","author":"B Saito","year":"2007","unstructured":"Saito B, Shiozawa E, Usui T, et al.: Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma. Leukemia 2007, 21:2563\u20132566.","journal-title":"Leukemia"},{"key":"59_CR48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/annonc\/mdj030","volume":"17","author":"KJ Savage","year":"2006","unstructured":"Savage KJ, Al-Rajhi N, Voss N, et al.: Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann Oncol 2006, 17:123\u2013130.","journal-title":"Ann Oncol"},{"key":"59_CR49","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1182\/blood-2007-08-108415","volume":"111","author":"E Vellenga","year":"2008","unstructured":"Vellenga E, van Putten WL, van \u2019t Veer MB, et al.: Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed\/progressive aggressive cCD20+ NHL: a prospective randomized HOVON trial. Blood 2008, 111:537\u2013543.","journal-title":"Blood"},{"key":"59_CR50","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","volume":"104","author":"DA Thomas","year":"2004","unstructured":"Thomas DA, O\u2019Brien S, Cortes J, et al.: Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood 2004, 104:1624\u20131630.","journal-title":"Blood"},{"key":"59_CR51","doi-asserted-by":"crossref","unstructured":"Abromowitch M, Termuhlen A, Chang M, et al.: High-dose methotrexate and early intensification of therapy do not improve 3\u00a0year EFS in children and adolescents with disseminated lymphoblastic lymphoma. Results of the randomized arms of COG A5971 [poster]. Blood (ASH Annual Meeting Abstracts) 2008, 112:Abstract 3610.","DOI":"10.1182\/blood.V112.11.3610.3610"},{"key":"59_CR52","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Reiter A: Diagnosis and treatment of childhood non-Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2007:285\u2013296. This article summarizes the results of recent multicenter studies on childhood lymphomas and discusses new treatment options for children with relapsed disease.","DOI":"10.1182\/asheducation-2007.1.285"},{"key":"59_CR53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2008.07393.x","volume":"144","author":"J Hochberg","year":"2009","unstructured":"Hochberg J, Waxman IM, Kelly KM, Morris E, Cairo MS. Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science. Br J Haematol 2009, 144:24\u201340.","journal-title":"Br J Haematol"},{"key":"59_CR54","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.2008.19.3367","volume":"27","author":"B Burkhardt","year":"2009","unstructured":"Burkhardt B, Reiter A, Landmann E, et al.: Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the Berlin-Frankfurt-Muenster Group. J Clin Oncol 2009, 27:3363\u20133369.","journal-title":"J Clin Oncol"},{"key":"59_CR55","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2001.19.11.2927","volume":"19","author":"JW Sweetenham","year":"2001","unstructured":"Sweetenham JW, Santini G, Qian W, et al.: High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation\/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group. J Clin Oncol 2001, 19:2927\u20132936.","journal-title":"J Clin Oncol"},{"key":"59_CR56","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2002-05-1483","volume":"101","author":"JE Levine","year":"2003","unstructured":"Levine JE, Harris RE, Loberiza FR Jr, et al.: A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood 2003, 101:2476\u20132482.","journal-title":"Blood"},{"key":"59_CR57","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood-2007-07-100958","volume":"111","author":"MC Deley Le","year":"2008","unstructured":"Le Deley MC, Reiter A, Williams D, et al.: Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European Intergroup Study. Blood 2008, 111:1560\u20131566.","journal-title":"Blood"},{"key":"59_CR58","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1309\/TLE8FN6EYF0NJGP7","volume":"121","author":"X Liang","year":"2004","unstructured":"Liang X, Meech SJ, Odom LF, et al.: Assessment of t(2, 5)(p23, q35) translocation and variants in pediatric ALK\u2009+\u2009anaplastic large cell lymphoma. Am J Clin Pathol 2004, 121:496\u2013506.","journal-title":"Am J Clin Pathol"},{"key":"59_CR59","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2141.2001.02896.x","volume":"114","author":"B Falini","year":"2001","unstructured":"Falini B: Anaplastic large cell lymphoma: pathological, molecular and clinical features. Br J Haematol 2001, 114:741\u2013760.","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"59_CR60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/annonc\/8.suppl_1.S37","volume":"8","author":"RE Hutchison","year":"1997","unstructured":"Hutchison RE, Banki K, Shuster JJ, et al.: Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood. Ann Oncol 1997, 8(Suppl 1):37\u201342.","journal-title":"Ann Oncol"},{"key":"59_CR61","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","volume":"93","author":"RD Gascoyne","year":"1999","unstructured":"Gascoyne RD, Aoun P, Wu D, et al.: Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999, 93:3913\u20133921.","journal-title":"Blood"},{"key":"59_CR62","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1200\/JCO.1994.12.5.899","volume":"12","author":"A Reiter","year":"1994","unstructured":"Reiter A, Schrappe M, Tiemann M, et al.: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-M\u00fcnster Group studies. J Clin Oncol 1994, 12:899\u2013908.","journal-title":"J Clin Oncol"},{"key":"59_CR63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1008352726155","volume":"11","author":"L Brugieres","year":"2000","unstructured":"Brugieres L, Quartier P, Le Deley MC, et al.: Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children: a report from the French Society of Pediatric Oncology. Ann Oncol 2000, 11:53\u201358.","journal-title":"Ann Oncol"},{"key":"59_CR64","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1200\/JCO.2008.20.1764","volume":"27","author":"L Brugieres","year":"2009","unstructured":"Brugieres L, Pacquement H, Le Deley MC, et al.: Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology. J Clin Oncol 2009, 27:5056\u20135061.","journal-title":"J Clin Oncol"},{"key":"59_CR65","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1701596","volume":"23","author":"R Fanin","year":"1999","unstructured":"Fanin R, Ruiz de Elvira MC, Sperotto A, et al.: Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1999, 23:437\u2013442.","journal-title":"Bone Marrow Transplant"},{"key":"59_CR66","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2141.2005.05910.x","volume":"132","author":"T Mori","year":"2006","unstructured":"Mori T, Takimoto T, Katano N, et al.: Recurrent childhood anaplastic large cell lymphoma: A retrospective analysis of registered cases in Japan. Br J Haematol 2006, 132:594\u2013597.","journal-title":"Br J Haematol"},{"key":"59_CR67","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2141.2006.06004.x","volume":"133","author":"W Woessmann","year":"2006","unstructured":"Woessmann W, Peters C, Lenhard M, et al.: Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents\u2014a Berlin-Frankfurt-M\u00fcnster Group report. Br J Haematol 2006, 133:176\u2013182.","journal-title":"Br J Haematol"},{"issue":"suppl 5","key":"59_CR68","first-page":"v62","volume":"16","author":"W Woessmann","year":"2005","unstructured":"Woessmann W, Lenhard M, Burkhardt B, et al.: Salvage strategy for anaplastic large cell lymphoma in children: prognostic impact of time to relapse and CD3 reactivity [abstract 090]. Ann Oncol 2005, 16(suppl 5):v62.","journal-title":"Ann Oncol"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-010-0059-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-010-0059-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-010-0059-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T14:42:46Z","timestamp":1591540966000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-010-0059-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,27]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s11899-010-0059-5","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,27]]}}}